UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000027523
Receipt number R000031499
Scientific Title Noncontrolled open-label exploratory clinical trial of additional infliximab therapy for patients with refractory Kawasaki disease who are refractory to intravenous immunoglobulin therapy, additional intravenous immunoglobulin therapy and first infliximab therapy.
Date of disclosure of the study information 2017/06/01
Last modified on 2020/05/31 19:24:19

No. Disposal Last modified on Item of update
1 Insert 2017/05/29 09:32:44
2 Update 2019/06/02 09:49:43 Recruitment status
Date of IRB
Last follow-up date
3 Update 2019/06/02 09:53:06 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
4 Update 2020/05/31 19:23:14 Number of participants that the trial has enrolled
Results
Results
Results date posted
Results Delayed
Results Delay Reason
Results Delay Reason
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures
5 Update 2020/05/31 19:24:19 Recruitment status